Overview of polymyxin resistance in Enterobacteriaceae

Kesia Esther da Silva1,2, Luana Rossato1, Andressa Ferraz Leite1

  • 1Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, MS, Brasil.

Insights

Polymyxin antibiotics are regaining interest for treating multidrug-resistant infections. This review details polymyxin resistance mechanisms and epidemiology, crucial for developing new treatments.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Polymyxin antibiotics, once disfavored due to toxicity (especially nephrotoxicity), are seeing renewed interest.
  • The rise of multidrug-resistant (MDR) gram-negative bacteria and a limited antibiotic pipeline necessitate exploring older drugs.
  • Polymyxins represent a critical last-resort treatment option for challenging infections.

Purpose of the Study:

  • To review current knowledge on polymyxin resistance mechanisms.
  • To summarize the molecular epidemiology of polymyxin-resistant pathogens.
  • To inform the development of novel antibacterial agents and treatment strategies.

Main Methods:

  • Literature review of existing studies on polymyxin resistance.
  • Analysis of molecular epidemiology data for relevant bacterial pathogens.
  • Synthesis of current information on resistance mechanisms and their prevalence.

Main Results:

  • Detailed overview of established and emerging polymyxin resistance mechanisms.
  • Information on the global distribution and trends of polymyxin resistance.
  • Identification of key resistance determinants and their genetic basis.

Conclusions:

  • Understanding polymyxin resistance is vital for effective clinical use.
  • Knowledge of resistance mechanisms and epidemiology aids in developing new drugs.
  • This review provides a foundation for future research and therapeutic interventions against MDR gram-negative infections.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
284
Antibiotic Selection00:57

Antibiotic Selection

Overview
55.8K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
416
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
116
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.0K